셀프케어와 재택 헬스케어에 대한 관심이 높아지면서, 환자가 임상 현장 밖에서도 사용하기 쉬운 IV 카테터에 대한 수요가 증가하고 있습니다. 자택에서 케어를 관리하고 약물을 자가 투여하는 환자가 증가함에 따라 비임상 환경에서 사용하기 쉽게 설계된 IV 카테터에 대한 수요가 높아지고 있습니다. 이처럼 셀프케어와 재택 헬스케어의 성장으로 시장 규모는 2024년 89억 2,000만 달러를 돌파하고 2031년에는 174억 9,000만 달러에 달할 것으로 전망됩니다.
병원 및 외래 수술 센터에서 이루어지는 수술 건수의 증가가 시장 확대에 기여하고 있습니다. 수액 카테터는 수술 중 및 수술 후 수액 주입, 투약, 영양 공급에 중요한 역할을 하기 때문에 수술 전후 치료의 필요성이 증가하고 있습니다. 이러한 외과 수술의 증가로 인해 수술 과정 전반에 걸쳐 환자 치료를 지원하는 다양한 IV 카테터 제품에 대한 수요가 증가하고 있습니다. 이처럼 외과 수술의 증가로 인해 시장은 2024년부터 2031년까지 연평균 8.78%의 CAGR로 성장할 것입니다.
IV(혈관 내) 카테터 시장 : 정의/개요
정맥 내(IV) 카테터는 정맥에 삽입되는 가늘고 유연한 튜브로, 수액, 약물, 혈액 제제를 혈류에 직접 전달하기 쉽도록 도와줍니다. 다양한 질환에 신속하고 효과적인 치료를 제공하기 위해 병원, 진료소, 재택의료 환경 등 다양한 헬스케어 환경에서 널리 활용되고 있는 필수 의료기기입니다.
IV 카테터는 소화기관을 우회하여 치료 물질을 투여할 수 있는 직접적이고 효율적인 경로를 제공합니다. 이 방법은 병으로 인해 식사나 수분을 경구로 섭취할 수 없는 환자나 빠른 약물 투여가 필요한 경우에 특히 유리합니다. 약물과 영양분을 혈류에 직접 주입함으로써 IV 카테터는 정확하고 즉각적인 치료 효과를 가능하게 하며, 이는 급성 증상 관리 및 지속적인 치료 지원에 매우 중요합니다.
병원 및 임상 현장뿐만 아니라 재택 간호 현장에서도 IV 카테터의 사용이 증가하고 있으며, 지속적인 또는 간헐적인 치료가 필요한 환자에게 필수적인 지원을 제공하고 있습니다. 다재다능하고 효율적인 정맥주사 치료는 현대 의료의 핵심으로, 종합적인 환자 치료를 촉진하고 다양한 의료 현장에서 치료 결과를 개선하고 있습니다.
의료 분야의 급속한 기술 발전과 혁신은 IV 카테터 시장의 성장을 촉진하고 있습니다. 최근의 동향으로는 새로운 말초 IV 카테터, 중심IV 카테터, 미드 라인 말초 카테터 등이 있으며, 이들은 환자의 혈류에 직접 수액이나 약물을 효율적으로 투여할 수 있도록 설계되어 있습니다. 이 카테터는 대부분 점진적으로 방출되는 약물로 코팅되어 있어 통증을 완화하고 염증을 억제하는 데 도움이 됩니다.
중심정맥관 삽입 카테터 시장은 특히 역동적이며, 팁의 디자인, 재료의 사용, 전달 메커니즘에 있어 기술 혁신이 계속되고 있습니다. 각 업체들은 고압을 견딜 수 있고 파워 인젝터블 시스템과 호환되는 첨단 바늘을 도입하고 있습니다. 이러한 개선은 환자의 편안함을 높이고 혈류 감염의 위험을 최소화하는 것을 목표로 하고 있으며, 시장 성장을 주도하고 있습니다.
다중 루멘 중심IV 카테터(CVC)에 대한 수요 증가는 주목할 만한 추세입니다. 멀티루멘 CVC는 정맥주사, 수혈, 임상 검사, 비경구 영양을 자주 필요로 하는 환자들에게 큰 이점이 있습니다. 카테터를 여러 번 삽입할 필요가 줄어들고, 감염의 위험도 낮아져 매우 바람직합니다. 공급업체들은 효율성을 높이고 판매량과 수익률을 높이기 위해 이러한 멀티루멘 카테터 개발 및 공급에 점점 더 많은 노력을 기울이고 있습니다.
기술 발전에는 카테터 재료를 강화하기 위한 나노기술의 활용도 포함됩니다. 나노스케일의 개선으로 생체적합성이 향상되고 혈전 형성성이 감소하여 혈전 형성의 위험이 감소합니다. 또한, 카테터에 항균 코팅을 하여 세균 증식을 방지하고 카테터 관련 감염 발생률을 낮출 수 있습니다. 카테터 삽입 가이드에 초음파 기술을 채택하여 정확도 향상, 합병증 감소, 시술 성공률 향상에 기여하고 있습니다. 이러한 기술 혁신은 중요한 문제를 해결하고 환자 결과를 개선하기 위해 전반적으로 세계 중심IV 카테터 시장의 성장을 주도하고 있습니다.
정맥 내 카테터에 대한 수요는 몇 가지 요인으로 인해 크게 증가할 것으로 예상됩니다. 정맥 내 카테터에 대한 규제 당국의 승인이 증가함에 따라 시장의 신뢰성과 가용성이 향상되고 있습니다. 신경질환, 심혈관질환, 비뇨기질환을 포함한 만성질환의 유병률 증가, 특히 노인 인구의 지속적인 증가로 인해 보다 빈번한 의료 개입이 필요해지면서 이러한 장비의 필요성이 높아지고 있습니다. 또한, 카테터 관련 혈류감염(CRBSI) 예방 및 관리에 대한 인식이 높아짐에 따라 수요가 더욱 증가할 것으로 예상됩니다. 의료진과 환자 모두 감염 예방과 환자 안전에 더욱 집중함에 따라 IV 카테터 사용은 예측 기간 동안 증가할 것으로 보입니다.
카테터 관련 혈류감염(CRBSI)과 같은 감염 위험. 이러한 감염은 심각한 문제이며, 의료 기관은 위험을 줄이기 위해 엄격한 프로토콜을 채택해야 합니다. 그러나 이러한 조치는 운영의 복잡성과 전체 비용을 증가시켜 의료 시스템과 제조업체를 모두 압박할 수 있습니다. 환자의 불편함도 심각한 문제입니다. IV 카테터를 삽입하고 유지하는 것은 통증과 불편함을 유발할 수 있으며, 이는 환자의 불만으로 이어질 수 있습니다. 이러한 불편함으로 인해 환자가 치료를 거부하거나 사용을 중단하는 경우도 있어 정맥 내 치료의 효과와 수용성에 영향을 미칠 수 있습니다.
제품 리콜도 큰 리스크가 될 수 있습니다. 합병증이나 제조상의 결함 등 카테터의 품질과 관련된 모든 문제는 리콜로 이어질 수 있습니다. 이러한 사고는 제조업체의 평판을 훼손하고 시장의 신뢰를 떨어뜨려 매출과 시장 역학에 영향을 미칠 수 있습니다. 비용 압박은 상황을 더욱 복잡하게 만들고 있습니다. 첨단 카테터 기술과 관련된 비용 상승과 지속적인 기술 혁신의 필요성은 제조업체의 가격 책정 및 수익성에 큰 압력을 가할 수 있습니다. 비용에 민감한 시장에서는 가격의 적정성과 기술 발전의 균형을 맞추는 것이 여전히 어려운 과제입니다.
또한, 규제상의 장애물도 상당한 걸림돌로 작용하고 있습니다. 장비 승인 및 시장 진입에 대한 엄격한 규제 요건은 개발 기간을 연장하고 비용을 증가시킵니다. 이러한 규제를 극복하기 위해서는 많은 투자와 자원이 필요하기 때문에 신제품 출시가 늦어지고 전체 시장 성장에 영향을 미칠 수 있습니다.
The increasing focus on self-care and home-based healthcare is driving the demand for IV catheters that are user-friendly for patients to use outside of clinical settings. As more patients manage their care and self-administer medications at home, there is a growing need for IV catheters designed for ease of use in non-clinical environments. Thus, the growth in self-care and home-based healthcare surged the growth of market size surpassing USD 8.92 Billion in 2024 to reach a valuation of USD 17.49 Billion by 2031.
The rising number of surgical procedures performed in hospitals and ambulatory surgical centers is contributing to the market's expansion. The need for IV catheters is heightened for perioperative and postoperative treatments, as they play a crucial role in administering fluids, medications, and nutrients during and after surgeries. This increase in surgical activity is driving demand for a wide range of IV catheter products to support patient care throughout the surgical process. Thus, the increasing number of surgical procedures enables the market to grow at a CAGR of 8.78% from 2024 to 2031.
IV (Intravascular) Catheter Market: Definition/ Overview
An intravenous (IV) catheter is a slender, flexible tube inserted into a vein to facilitate the direct delivery of fluids, medications, or blood products into the bloodstream. This essential medical device is widely utilized across various healthcare settings, including hospitals, clinics, and home care environments, to provide swift and effective treatment for a range of medical conditions.
IV catheters offer a direct and efficient route for administering therapeutic substances, bypassing the digestive system. This method is particularly advantageous for patients who are unable to consume food or fluids orally due to medical conditions, or when there is a need for rapid medication delivery. By ensuring that medications and nutrients are introduced directly into the bloodstream, IV catheters enable precise and immediate therapeutic effects, which is crucial for managing acute conditions and supporting ongoing treatments.
In addition to their use in hospital and clinical environments, IV catheters are increasingly employed in home care settings, where they provide vital support for patients requiring continuous or intermittent treatments. The versatility and efficiency of IV therapy make it a cornerstone of modern medical practice, facilitating comprehensive patient care and enhancing treatment outcomes across diverse healthcare scenarios.
Rapid technological advancements and innovations in the medical sector surge the growth of IV catheters market. Recent developments include novel peripheral IV catheters, central venous catheters, and midline peripheral catheters, which are designed to efficiently administer fluids and medications directly into the patient's bloodstream. Many of these catheters are coated with medications that are gradually released, helping to alleviate pain and reduce inflammation.
The market for central IV catheters is particularly dynamic, with ongoing innovations in tip design, material usage, and delivery mechanisms. Vendors are introducing advanced needles that can withstand high pressure and are compatible with power injectable systems. These improvements aim to enhance patient comfort and minimize the risk of bloodstream infections, driving market growth.
The rising demand for multi-lumen central venous catheters (CVCs) is a notable trend. Multi-lumen CVCs offer significant advantages for patients who require frequent intravenous medications, blood transfusions, laboratory tests, and parenteral nutrition. They reduce the need for multiple catheter insertions and lower the risk of infections, making them highly desirable. Vendors are increasingly focused on developing and offering these multi-lumen catheters to enhance efficiency and improve sales volume and profit margins.
Technological advancements also include the use of nanotechnology to enhance catheter materials. Nanoscale modifications improve biocompatibility and reduce thrombogenicity, which decreases the risk of clot formation. Additionally, integrating antimicrobial coatings on catheters helps prevent bacterial growth, reducing the incidence of catheter-related infections. Ultrasound technology is being employed to guide catheter insertion, which improves accuracy, reduces complications, and increases the success rate of procedures. These innovations collectively drive the growth of the global central IV catheter market, as they address key challenges and improve patient outcomes.
The demand for intravenous catheters is expected to rise significantly due to several factors. Increasing regulatory approvals for IV catheters are boosting market confidence and availability. The growing incidence of chronic disorders, including neurological, cardiovascular, and urological conditions, is driving the need for these devices, particularly as the elderly population continues to expand and requires more frequent medical interventions. Additionally, heightened awareness regarding the prevention and control of catheter-related bloodstream infections (CRBSI) is anticipated to further fuel demand. As both healthcare providers and patients become more focused on infection control and improving patient safety, the use of intravenous catheters is likely to increase throughout the forecast period.
The risk of infection, such as catheter-related bloodstream infections (CRBSIs). These infections present significant challenges, prompting healthcare facilities to adopt stringent protocols to mitigate risks. However, these measures can increase operational complexities and overall costs, adding pressure to healthcare systems and manufacturers alike. Patient discomfort is another critical issue. The insertion and maintenance of IV catheters can cause pain and discomfort, which may lead to patient dissatisfaction. This discomfort can sometimes result in patients refusing treatment or discontinuing use, affecting the effectiveness and acceptance of IV therapy.
Product recalls pose a substantial risk as well. Any issues related to catheter quality, such as complications or manufacturing defects, can lead to recalls. Such incidents damage the reputation of manufacturers and undermine market confidence, potentially impacting sales and market dynamics. Cost pressures further complicate the landscape. The rising costs associated with advanced catheter technologies and the need for continual innovation can exert significant pressure on pricing and profitability for manufacturers. Balancing affordability with technological advancements remains a challenge in a cost-sensitive market.
Additionally, regulatory hurdles are a considerable restraint. The stringent regulatory requirements for device approval and market entry can extend development timelines and increase costs. Navigating these regulations requires substantial investment and resources, which can delay the introduction of new products and impact overall market growth.
The peripheral IV catheter segment significantly dominates the IV catheter market. Peripheral intravenous catheters (PIVCs) are increasingly favored in clinical settings for their ease of installation and removal, offering a more comfortable and minimally invasive option for obtaining intravenous therapy. This approach enhances patient satisfaction and proves to be more cost-effective compared to midline peripheral catheters and central venous catheters. The low cost of PIVCs, coupled with their user-friendly nature, positions them as a popular choice in various medical procedures.
The market for PIVCs is expected to experience growth driven by strategic initiatives from industry players, such as the introduction of innovative products, strategic partnerships, and mergers and acquisitions. This peripheral catheter significantly reduces the risk of needle stick injuries and blood exposure, contributing to safer intravenous access for healthcare providers.
Furthermore, the increasing preference for minimally invasive procedures is fueling the demand for PIVCs. These procedures are associated with shorter recovery times, reduced discomfort, and lower risk of complications, making them appealing for both patients and healthcare practitioners. PIVCs are commonly used to administer anesthetics and medications during such procedures, underscoring their importance in modern medical practices. As the adoption of minimally invasive techniques continues to rise, the demand for PIVCs is expected to grow, driven by their practical benefits and the ongoing evolution of medical technologies.
The Hospital Pharmacies segment significantly dominates the IV Catheter Market. The global increase in hospitalization rates and the growing volume of medical procedures requiring IV fluid and solution infusion are major drivers of the IV catheter market. Hospitals remain the primary setting for IV catheter use, accounting for the majority of sales and continuing to dominate the market.
In these healthcare facilities, hospital pharmacies and stores play a crucial role in the distribution and storage of pharmaceuticals, including IV catheters. These on-site pharmacies manage a broad range of medications, from standard treatments to specialized and experimental drugs. As hospitals prioritize patient safety, there is a significant focus on minimizing the risks associated with IV catheter use, such as infections and complications.
In addition, to these concerns, hospitals are increasingly demanding IV catheters that feature advanced safety features. For instance, IV catheters with antimicrobial coatings are sought after for their ability to reduce infection risks, while needleless connectors are preferred for their role in minimizing needle-stick injuries and enhancing overall safety. This trend highlights the hospital's commitment to improving patient outcomes and safety through the adoption of more sophisticated and safer catheter technologies.
Gain Access to IV (Intravascular) Catheter Market Report Methodology
North America substantially dominates the IV (Intravascular) catheter market. The increasing prevalence of chronic disorders and the rising geriatric population contribute to a higher demand for IV catheters, driven further by the presence of leading manufacturers such as Boston Scientific Corporation, BD, and Teleflex Incorporated. These companies are positively impacting regional market growth through their innovations and market activities. The extensive network of hospitals, clinics, and ambulatory care centers worldwide creates a substantial and consistent demand for IV catheters. The broad availability of these healthcare facilities ensures that a large patient base, requiring intravenous treatments for various conditions, has reliable access to essential catheter devices. The increasing global elderly population is particularly susceptible to chronic diseases that often necessitate prolonged or frequent IV therapy. As the number of aging individuals rises, so does the need for IV catheters to manage age-related health issues effectively and provide ongoing medical care.
Favorable government policies, heightened public awareness, and the presence of highly qualified medical professionals and renowned healthcare facilities further bolster the market's expansion in North America. The high incidence of chronic diseases is anticipated to increase hospital admissions, which in turn will drive demand for vascular catheterization and vein access treatments. Innovations such as advanced biocompatible materials, antimicrobial coatings, and user-friendly designs are improving patient outcomes and driving market growth. These advancements contribute to safer, more effective catheterization processes, benefiting patients and healthcare providers.
Additionally, strategic initiatives by market players, including product innovations and various other activities, are contributing to the region's market growth. North America is expected to hold the largest share of the intravascular catheters market during the forecast period, largely due to the increasing incidence of renal diseases. The increasing emphasis on reducing healthcare-associated infections (HAIs) and improving patient safety. This focus has led to the development and adoption of advanced IV catheters equipped with features such as needleless connectors and antimicrobial coatings. Stringent regulations and guidelines surrounding infection control are propelling the market for these advanced safety-oriented products.
How the Increasing Investments in the Healthcare Sector and Growing Incidence of Chronic Conditions Foster the Growth of IV (Intravascular) Catheter Market?Bottom of Form
Investments in expanding and upgrading healthcare facilities fueling strong demand for medical devices, including IV catheters. The establishment of new hospitals, clinics, and specialized care centers, along with the enhancement of existing infrastructure, ensures that a wide array of medical devices, including IV catheters, are required to support advanced patient care. The growing incidence of chronic conditions such as diabetes, cancer, and cardiovascular diseases is driving a heightened need for long-term IV therapy. As these diseases become more prevalent, the demand for IV catheters increases, given their essential role in the ongoing management and treatment of these conditions. In countries like Japan and South Korea, the rapidly aging population is leading to a greater need for IV catheters. Older adults are more prone to chronic illnesses and age-related health issues that often require intravenous treatment. This demographic shift is substantially driving the demand for IV catheters to address the specific needs of the elderly.
Increasing disposable incomes are enhancing access to healthcare services and advanced medical treatments. As individuals' financial capabilities improve, they are more likely to seek high-quality medical care and invest in advanced medical technologies, including IV catheters. This rise in disposable income contributing to the broader adoption of these medical devices. Government support for healthcare infrastructure development and a strong emphasis on patient safety are pivotal in driving market growth. Various government initiatives aim to improve healthcare access, implement rigorous infection control measures, and promote the use of advanced medical devices. These efforts are supporting the expansion of the IV catheter market by fostering a safer and more efficient healthcare environment.
The IV (Intravascular) catheter market is characterized by a mix of established global players and regional manufacturers. The industry is highly competitive, with companies focused on product innovation, cost-efficiency, and strong distribution networks.
The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the IV (Intravascular) catheter market include: